89 related articles for article (PubMed ID: 12039466)
1. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions.
Humbey O; Aubin F; Cairey-Remonnay S; Riethmuller D; Pretet JL; Fest T; Seilles E; Mougin C
Eur J Obstet Gynecol Reprod Biol; 2002 Jun; 103(1):60-4. PubMed ID: 12039466
[TBL] [Abstract][Full Text] [Related]
2. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
3. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas.
Humbey O; Cairey-Remonnay S; Guérrini JS; Algros MP; Mougin C; Bittard H; Aubin F
Eur J Cancer; 2003 Mar; 39(5):684-90. PubMed ID: 12628849
[TBL] [Abstract][Full Text] [Related]
4. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
5. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
7. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
10. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix.
Giannoudis A; Graham DA; Southern SA; Herrington CS
Int J Cancer; 1999 Sep; 83(1):66-9. PubMed ID: 10449610
[TBL] [Abstract][Full Text] [Related]
14. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status.
Cairey-Remonnay S; Humbey O; Mougin C; Algros MP; Mauny F; Kanitakis J; Euvrard S; Laurent R; Aubin F
J Invest Dermatol; 2002 Jun; 118(6):1026-31. PubMed ID: 12060398
[TBL] [Abstract][Full Text] [Related]
15. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
[TBL] [Abstract][Full Text] [Related]
16. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.
Zappacosta B; Romano L; Guerriero M; Graziano M; Vitrani A; De Ninno M; Carbone A
New Microbiol; 2009 Oct; 32(4):351-8. PubMed ID: 20128441
[TBL] [Abstract][Full Text] [Related]
17. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.
Burroni E; Bisanzi S; Sani C; Puliti D; Carozzi F
J Med Virol; 2013 Jan; 85(1):83-90. PubMed ID: 23124863
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
19. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
20. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
